Skip to content
OpenCapital
Get started

USANA Health Sciences USNA Return on equity

Return on equity at other companies

Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
11.9%+5.5pp
United Natural Foods logo
United Natural FoodsUNFI
-2.4%-0.7pp
Natural Grocers by Vitamin Cottage logo
Natural Grocers by Vitamin CottageNGVC
22.7%-0.6pp
US Foods logo
US FoodsUSFD
15.1%+4.0pp
Universal Corporation logo
Universal CorporationUVV
5.8%-3.0pp
Archer Daniels Midland logo
Archer Daniels MidlandADM
4.8%—

Other financials

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total debt$18.0M+10.8%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
Operating cash flow$9.8M-37.0%
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation

See full
Market cap$363.35M-36.1%
P/E18.1×+7.8×
P/S0.4×-0.3×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp
Net margin1.9%-4.4pp
FCF margin5.7%-1.1pp

Returns & leverage

See full
Debt / equity0×0.0×
Current ratio2.5×+0.5×

Where this comes from

Calculated from USANA Health Sciences’s reported figures.

net income/total stockholders equity=3.2%

Based on trailing twelve months.

The official record: USANA Health Sciences’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USANA Health Sciences's return on equity?
USANA Health Sciences (USNA) reported return on equity of 3.2% in Q3 2025.
How has USANA Health Sciences's return on equity changed year-over-year?
USANA Health Sciences's return on equity decreased by 70.4% year-over-year, from 10.8% to 3.2%.
What is the long-term trend for USANA Health Sciences's return on equity?
Over 4 years (2020 to 2024), USANA Health Sciences's return on equity has grown at a -28.6% compound annual growth rate (CAGR), from 31.4% to 8.2%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.